Pain Management Peptides
Peptides investigated for pain management and analgesic properties. Includes opioid peptides, anti-inflammatory peptides, and novel compounds targeting pain signaling pathways.
Other Categories
Related Categories
Botulinum Toxin
Botulinum toxin: FDA-approved neurotoxin guide. Covers SNARE mechanism, Botox vs Dysport, migraine and spasticity uses, dosing, and safety profile.
Cebranopadol
Cebranopadol (GRT-6005): first-in-class dual NOP/opioid receptor agonist for pain. Phase 3 ALLEVIATE trials positive. FDA Fast Track for chronic low back pain.
Dermorphin
Dermorphin: Potent frog-derived opioid peptide with 40x morphine selectivity. Covers mu-opioid mechanism, analgesic research, and safety concerns.
Ziconotide
Ziconotide (Prialt): FDA-approved intrathecal peptide from cone snail venom. Blocks N-type calcium channels for severe chronic pain refractory to other therapies.
Head-to-Head Comparisons
Detailed comparisons between pain management peptides covering mechanisms, efficacy, side effects, and research evidence.
Research Tools
Use our interactive tools to explore pain management peptides further.